دسترسی یکساله به بیش از ۵۰۰ ژورنال روز جهان موجود در سامانه
-
http://medilib.ir
- ﻣﺪﺕ ﺯﻣﺎﻥ : 365 ﺭﻭﺯ
قیمت : 3,800,000 تومان- قیمت ویژه : 1,900,000تومان
Inside This Issue
doi : 10.1016/S1936-8798(21)00446-5
Volume 14, Issue 7, 12 April 2021, Pages A15-A18
Antithrombotic Management of Elderly Patients With Coronary Artery Disease
PieraCapranzanoMD, PhDaDominick J.AngiolilloMD, PhDb
doi : 10.1016/j.jcin.2021.01.040
Volume 14, Issue 7, 12 April 2021, Pages 723-738
Effect of CYP2C19 Genotype on Ischemic Outcomes During Oral P2Y12 Inhibitor Therapy: A Meta-Analysis
Naveen L.PereiraMDaCharanjitRihalMDaRyanLennonMSbGilMarcusMDcSanskritiShrivastavaMBBSaMalcolm R.BellMDaDerekSoMDdNancyGellerPhDeShaun G.GoodmanMD, MScfgAhmedHasanMD, PhDeAmirLermanMDaYvesRosenbergMD, MPHeKentBaileyPhDbM. HassanMuradMD, MPHhMichael E.FarkouhMD, MScc
doi : 10.1016/j.jcin.2021.01.024
Volume 14, Issue 7, 12 April 2021, Pages 739-750
The aim of this study was to examine the effect of CYP2C19 genotype on clinical outcomes in patients with coronary artery disease (CAD) who predominantly underwent percutaneous coronary intervention (PCI), comparing those treated with ticagrelor or prasugrel versus clopidogrel.
Genotype-Guided Antiplatelet Therapy in Patients With Coronary Artery Disease?
FrancescoFranchiMDFabianaRolliniMD
doi : 10.1016/j.jcin.2021.02.005
Volume 14, Issue 7, 12 April 2021, Pages 751-753
Uninterrupted Oral Anticoagulant Therapy in Patients Undergoing Unplanned Percutaneous Coronary Intervention
DimitriosVenetsanosMD, PhDaMikolajSkibniewskiMDbMagnusJanzonMD, PhDbSofia S.LawessonMD, PhDbEmmanouilCharitakisMD, PhDbFelixB?hmMD, PhDaLoghmanHenarehMD, PhDaPontusAndellMD, PhDaLars O.KarlssonMD, PhDbMoaSimonssonMDaSebastianV?lzMD, PhDcDavidErlingeMD, PhDdElmirOmerovicMD, PhDcJoakimAlfredssonMD, PhDb
doi : 10.1016/j.jcin.2021.01.022
Volume 14, Issue 7, 12 April 2021, Pages 754-763
This study sought to compare interrupted and uninterrupted oral anticoagulant therapy (I-OAC vs. U-OAC) in patients on OAC undergoing percutaneous coronary intervention.
Evidence and Recommendations for Uninterrupted Versus Interrupted Oral Anticoagulation in Patients Undergoing Percutaneous Coronary Intervention?
PieraCapranzanoMD, PhDaDominick J.AngiolilloMD, PhDb
doi : 10.1016/j.jcin.2021.02.019
Volume 14, Issue 7, 12 April 2021, Pages 764-767
Evaluation of Dual Versus Triple Therapy by Landmark Analysis in the RE-DUAL PCI Trial
Benjamin E.PetersonMD, MPHaDeepak L.BhattMD, MPHaPh.Gabriel StegMDbJonasOldgrenMD, PhDcMichaelMaengMD, PhDdUweZeymerMDeSigrunHalvorsenMDfStefan H.HohnloserMDgGregory Y.H.LipMDhiTakeshiKimuraMDjMatiasNordabyMDkCorinnaMiedeMSclEvaKleineMSckJurriën M.ten BergMDmnChristopher P.CannonMDaRE-DUAL PCI Steering Committee and Investigators
doi : 10.1016/j.jcin.2021.02.022
Volume 14, Issue 7, 12 April 2021, Pages 768-780
The aim of this study was to explore the early versus late benefits and risks of dabigatran dual therapy versus warfarin triple therapy in the RE-DUAL PCI (Randomized Evaluation of Dual Antithrombotic Therapy With Dabigatran Versus Triple Therapy With Warfarin in Patients With Nonvalvular Atrial Fibrillation Undergoing Percutaneous Coronary Intervention) trial.
Triple Therapy, Dual Therapy, and Modulation of Anticoagulation Intensity?
DavideCapodannoMD, PhD
doi : 10.1016/j.jcin.2021.02.039
Volume 14, Issue 7, 12 April 2021, Pages 781-784
Stable Clinical Outcomes When a Stroke Thrombectomy Program Is Started in an Experienced Cardiology Cath Lab
JakubSul?enkoMD, PhDaBorisKo?narMD, PhDaTom??PeiskerMD, PhDbPeterVa?koMD, PhDbJanaVavrov?MDbIvana?t?tk??ov?MD, CScbPetrWidimsk?MD, DrSca
doi : 10.1016/j.jcin.2021.01.025
Volume 14, Issue 7, 12 April 2021, Pages 785-792
This study analyzed the learning curve effect when a new stroke thrombectomy program was initiated in a cardiac cath lab in close cooperation with neurologists and radiologists.
It Is Time to Fight Ischemic Stroke the Best Possible Way?
MariusHornungMDabHorstSievertMDac
doi : 10.1016/j.jcin.2021.02.017
Volume 14, Issue 7, 12 April 2021, Pages 793-795
The Role for Combined Antithrombotic Therapy With Platelet and Coagulation Inhibition After Lower Extremity Revascularization
E. HopeWeisslerMDaVictorAboyansMDbRupertBauersachsMDcdMarianneBrodmannMDeSigridNikolMDfSebastianDebusMDgManesh R.PatelMDhW. SchuylerJonesMDh
doi : 10.1016/j.jcin.2021.01.035
Volume 14, Issue 7, 12 April 2021, Pages 796-802
Evidence for antithrombotic treatment following lower extremity revascularization (LER) for peripheral artery disease (PAD) is limited, leading to weak and conflicting guideline recommendations and heterogeneous practice patterns. This variability in post-LER antithrombotic treatment raises quality-of-care issues that have long been under-studied. This Viewpoint reviews the most updated guidelines, currently-available evidence, and contemporary data about practice patterns and practitioner opinions in this area. Particular attention is paid to distinctions between antiplatelet therapy, anticoagulant therapy, and combination therapy in light of the recent VOYAGER-PAD (Vascular Outcomes Study of ASA [acetylsalicylic acid] Along with Rivaroxaban in Endovascular or Surgical Limb Revascularization for PAD) trial. The implications of VOYAGER-PAD pertaining to various subgroups of patients undergoing LER are explored. Overall, this Viewpoint argues for consideration of post-LER therapy targeted at both platelet function and the coagulation cascade, though further LER-specific analyses, including expected VOYAGER-PAD sub-analyses, are needed.
3D Wiring in CTO Intervention: Cracking the Code
Pravin K.GoelMDAnkit KumarSahuMD
doi : 10.1016/j.jcin.2021.02.012
Volume 14, Issue 7, 12 April 2021, Pages 803-806
ST-Segment Elevation Myocardial Infarction in the Morbidly Obese: Use of the “Offloading” Technique
SripalBangaloreMD, MHALindaKoshyMDCarlosAlviarMDCraigThompsonMDNormaKellerMD
doi : 10.1016/j.jcin.2020.12.017
Volume 14, Issue 7, 12 April 2021, Pages 807-808
Syphilitic Aortitis Causing Severe Bilateral Coronary Ostial Stenosis
LinBaiMD?MianWangMD?YongPengMD
doi : 10.1016/j.jcin.2021.01.023
Volume 14, Issue 7, 12 April 2021, Pages e65-e67
Dual Ostia Right Coronary Artery: A Newly Described Coronary Anomaly
TeodoraDonisanMDaLuaySayedMDb
doi : 10.1016/j.jcin.2020.12.032
Volume 14, Issue 7, 12 April 2021, Pages e69-e70
A ST-Segment Elevation Myocardial Infarction Mimic in a Young Male
HongboYangMD?JiatianCaoPhD?YananSongMD?ZheyongHuangPhDJuyingQianPhDJunboGePhD
doi : 10.1016/j.jcin.2021.01.032
Volume 14, Issue 7, 12 April 2021, Pages e71-e72
Posterior Reversible Encephalopathy Syndrome: A Rare and Cautionary Complication During Percutaneous Coronary Intervention
HiroyukiYamamotoMD, PhDaTomofumiTakayaMD, PhDabHiroshiTsunamotoMDaYoshiroTsukiyamaMD, PhDaTaichiroAshizakiMDcHiroyaKawaiMD, PhDab
doi : 10.1016/j.jcin.2021.01.036
Volume 14, Issue 7, 12 April 2021, Pages e73-e75
Efficacy and Safety of Low-Dose Systemic Fibrinolytic Therapy for Acute Submassive Pulmonary Embolism
AhmetGünerMDEzgi GültekinGünerMDSedaKarakurtMDMacitKalç?kMD
doi : 10.1016/j.jcin.2021.01.043
Volume 14, Issue 7, 12 April 2021, Page 809
Reply: Efficacy and Safety of Low-Dose Systemic Fibrinolytic Therapy for Acute Submassive Pulmonary Embolism
Akhilesh K.SistaMDJames M.HorowitzMDVictor F.TapsonMDJames F.BenenatiMD
doi : 10.1016/j.jcin.2021.02.009
Volume 14, Issue 7, 12 April 2021, Page 810
Use All 3 Motor-Driven Axes of Angiocardiographic Systems for Multiple Optimal Fluoroscopic Projections During TAVR
FrançoisDérimayMD, PhDGillesRioufolMD, PhDGérardFinetMD, PhD
doi : 10.1016/j.jcin.2021.02.002
Volume 14, Issue 7, 12 April 2021, Pages 810-811
Reply: Use All 3 Motor-Driven Axes of Angiocardiographic Systems for Multiple Optimal Fluoroscopic Projections During TAVR
JeremyBen-ShoshanMD, PhDPascal ThériaultLauzierMD, PhDNicoloPiazzaMD, PhD
doi : 10.1016/j.jcin.2021.02.042
Volume 14, Issue 7, 12 April 2021, Pages 811-812
Initial Outcomes of AnteOwl IVUS–Based 3D Wiring Using the Tip Detection Method for CTO Intervention
SatoshiSuzukiMDAtsunoriOkamuraMDKatsuomiIwakuraMDMutsumiIwamotoMDSatoshiWatanabeMDHiroyukiNagaiMDAkinoriSumiyoshiMDIchiroShiojimaMDYasushiSakataMDKenshiFujiiMD
doi : 10.1016/j.jcin.2021.01.048
Volume 14, Issue 7, 12 April 2021, Pages 812-814
Transvenous, Echocardiographically Guided Closure of Persistent Ductus Arteriosus in 11 Premature Infants: A Pilot Study
StanimirGeorgievMDDanielTanaseMDAndreasEickenMDJochenPetersPhDJürgenH?rerMDPeterEwertPhD
doi : 10.1016/j.jcin.2021.01.009
Volume 14, Issue 7, 12 April 2021, Pages 814-816
5-Year Outcomes From the Harmony Native Outflow Tract Early Feasibility Study
Matthew J.GillespieMDLisaBergersenMD, MPHLee N.BensonMDShichengWengMSJohn P.CheathamMD
doi : 10.1016/j.jcin.2021.01.046
Volume 14, Issue 7, 12 April 2021, Pages 816-817
